We are testing whether ravulizumab can help preserve kidney function in adults with immunoglobulin A nephropathy. The study will also assess safety and quality of life compared to a placebo.
Health conditions and diseases that the clinical trial is designed to study and treat.
Immunoglobulin A Nephropathy (IgAN) is a kidney disorder where IgA, a type of antibody, builds up in the kidneys, leading to inflammation and potential kidney damage. It can cause symptoms like blood in urine, protein in urine, and swelling in the legs and feet.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
